Trials / Completed
CompletedNCT02050074
The Role of Metformin and Colesevelam in Human GLP-1 Secretion
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University Hospital, Gentofte, Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Our primary hypothesis is that bile acid sequestrant colesevelam and the antidiabetic drug metformin potentiates the secretion of the gut hormone glucagon-like peptide 1 (GLP-1).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colesevelam | |
| DRUG | Metformin | |
| OTHER | Placebo |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2014-01-30
- Last updated
- 2014-10-07
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02050074. Inclusion in this directory is not an endorsement.